Pancreatic ATP-sensitive potassium channel complex (Pancreatic KATP channel) (Pancreatic KATP channel)

The pancreatic ATP-sensitive potassium (KATP) channel complex is a hetero-octameric protein assembly essential for regulating insulin secretion in pancreatic beta cells. It is composed of four pore-forming inward-rectifier potassium channel subunits (Kir6.2) and four regulatory sulfonylurea receptor 1 (SUR1) subunits (UniProt: P48544, Q09428). This complex functions as a metabolic sensor by coupling the intracellular ATP/ADP ratio to the cell's membrane potential. When glucose levels rise, increased ATP production leads to channel closure, triggering membrane depolarization, calcium influx, and the exocytosis of insulin granules (StatPearls: NBK525982). Mutations in the genes encoding these subunits, KCNJ11 and ABCC8, are linked to clinical conditions such as neonatal diabetes and congenital hyperinsulinism (PubMed: PMC2674953). Therapeutically, the complex is the primary target for sulfonylureas and glinides, which promote insulin release in type 2 diabetes patients. Conversely, channel openers like diazoxide are used to manage hypoglycemia by inhibiting insulin secretion (StatPearls: NBK545283). The channel's activity is also modulated by various intracellular signaling molecules, including phosphoinositides and long-chain acyl-CoAs. Understanding the structural basis of this complex has been crucial for developing drugs with higher specificity for the pancreatic isoform over cardiac or vascular variants.

Other names

Kir6.2/SUR1 complexATP-sensitive potassium channelKATP channelSulfonylurea receptor 1-inward rectifier potassium channel 6.2 complex

Sulfonylureas and meglitinides act as channel closers by binding to the SUR1 subunit, inducing membrane depolarization and insulin release; conversely, potassium channel openers like diazoxide stabilize the open state to inhibit insulin secretion (StatPearls: NBK545283).